FTSE News: FTSE 100, FTSE 250, and FTSE 400 investment news
FTSE market news from the London Stock Exchange: FTSE 100, FTSE 250, and FTSE 400

Latest FTSE News:

  • Miners gain, house builders see declines

  • Oil, miners higher in London

  • Telecoms, retailers see gains

  • Pharma lower in London

  • British Energy drops on nuclear plant delays

  • Home builders see gains in London

  • House builders, property developers down in London

  • Brewers higher on bids rumors

  • Oil sector, banks mixed in London

  • BP, Royal Dutch Shell gain on higher oil prices

  • FTSE news feed

    Recommended equities news sites

  • Eurofirst News
  • Tokyo Market News
  • NYSE News
  • FTSE
  • London Stock Exchange
  •  

    November 30, 2006

    Most UK miners see gains

    Filed under: Companies, GlaxoSmithKline, Xstrata, Anglo American, Rio Tinto, BHP Billiton, AstraZeneca, Shire, Rank Group, Hanson

    London’s equities markets were mixed on Thursday as the FTSE 100 dropped 0.6 percent to 6,048.9 but the FTSE 250 added 0.1 percent to 10,673.9.

    Miners were mostly up on the session, the exception being Anglo American, which dropped 0.25 percent to £23.62. Rio Tinto added 0.8 percent to £27.15, while Xstrata and BHP Billiton gained 1.1 percent each, to £22.80 and 965p respectively. Analysts at Citigroup issued remarks saying that Billiton should divest itself of its petroleum unit and that Rio Tinto should get rid of its Industrial Minerals division in order to kick-start performance.

    The pharmaceuticals sector saw declines. GlaxoSmithKline dropped 1.4 percent to £13.51, while AstraZeneca fell 1.9 percent to £29.50 and Shire was 2.1 percent lower to £10.19. There has been talk lately that GlaxoSmithKline might be interested in AstraZeneca, but some analysts believe that AstraZeneca is more likely to be a bidder, possibly for Shire, than a target of bids.

    Building materials group Hanson added 0.5 percent to 729p on rumors that Mexico’s Cemex could be interested in bidding, especially after its bid for an Australian company was rejected earlier in the week. Meanwhile in the leisure sector, casino operator Rank was 2 percent higher to 278p on rumors that it could be a target for bidders.





    November 29, 2006

    FTSE 250 adds 1.5 percent

    Filed under: Companies, Prudential, GlaxoSmithKline, Xstrata, BHP Billiton, AstraZeneca, Shire, Legal & General, Sage

    The London equities markets were higher on Wednesday in reaction to overnight gains in New York and Tokyo, while the pharmaceuticals sector was higher and financial services gained on bids rumors. The FTSE 100 added 0.6 percent to 6,065.3, while the FTSE 250 gained 1.5 percent to 10,659.1.

    Miners were up on higher prices for several metals. BHP Billiton added 1.8 percent to 954p, while Xstrata was 2.1 percent higher to £22.49.

    In the pharmaceuticals sector, AstraZeneca was up 2.5 percent to £30.03. Shire added 2.7 percent to £10.34 on an upgrade from “neutral” to “overweight” from HSBC, while GlaxoSmithKline gained 3 percent to £13.71. Gains in the sector were helped by news that Swiss pharma group Novartis is thinking of selling its baby food unit, Gerber Products, to Nestle.

    Among financial services groups, Prudential was 2.1 percent higher to 660p on rumors that HSBC could be interested, while Legal & General added 3 percent to 154p on talk that Dutch insurer Aegon was thinking of bidding.

    In the software sector, Sage added 6.2 percent to 256p on its report that its pre-tax profits were up 14 percent in the quarter. Meanwhile plumber Wolseley gained 3.8 percent to £11.78 even though its fiscal first quarter profits were up only slightly.





    November 10, 2006

    FTSE 100 drops on day

    Filed under: Companies, GlaxoSmithKline, Anglo American, Lonmin, International Power, AstraZeneca, Crest Nicholson, Severn Trent

    The FTSE 100 dropped 0.37 percent on Friday to end the week at 6,208.4 in a week where at least some stocks in the UK were affected by the elections in the United States on Tuesday.

    The pharmaceuticals sector declined in the wake of the Democratic takeover of both houses of Congress on the concern that drug prices could be affected by legislation promised by House speaker-elect Nancy Pelosi to allow direct governmental negotiation of drug prices for recipients of Medicare. GlaxoSmithKline dropped 1.8 percent to £13.61, while AstraZeneca was 2.8 percent lower to £30.03.

    Utilities were lower on speculation about takeovers in the sector after Scottish Power said that it had been approached by Spain’s Iberdrola. International Power dropped 1.6 percent to 338¼p, while Severn Trent was 1.7 percent lower to £14.03.

    Among the mid-caps, homebuilder Crest Nicholson was 8.9 percent higher to 622½p after it rejected an offer from a group that included the Bank of Scotland.

    Miners were higher on positive broker comments and bids rumors. Anglo American added 2.8 percent to £25.56 after one of the richest men in China bought a 1.1 percent stake in the miner, raising speculation that there could be a bid for the company out of China. Lonmin added 8.6 percent to £33.55 after Morgan Stanley raised its target share price to £40.





    October 25, 2006

    FTSE 250 sets another closing record

    Filed under: Companies, GlaxoSmithKline, BAT, AstraZeneca, Wolfson Microelectronics, Imperial Tobacco, Gallaher, Misys

    The London equities markets were higher on Wednesday on gains in the tobacco and oil sectors. The oil sector was higher after US inventory numbers showed that stockpiles of crude oil, gasoline, and heating oil were all lower last week. The FTSE 100 added 0.5 percent to 6,214.6 percent, while the FTSE 250 gained 0.2 percent to close at 10,425.4, another new record.

    Imperial Tobacco Group was 1.6 percent higher to £18.55 ahead of its full-year report, due next week. British American Tobacco, which is scheduled to release its third quarter report later on Wednesday, added 2.5 percent to £14.82 on strong results from Reynolds American. BAT holds 42 percent of Reynolds, which also learned that a US appeals court on the federal level will hear arguments concerning whether a case looking for $200 billion from tobacco companies can be conducted as a class action suit. Meanwhile, Gallaher gained 3.1 percent to 884½p on bids rumors and positive comments.

    The pharmaceuticals sector was mixed after UBS upgraded the sector to “overweight”. GlaxoSmithKline added 1.5 percent to £15.11 ahead of the announcement of its third quarter results, but AstraZeneca fell 1.2 percent to £35.92.

    Chipmaker Wolfson Microelectronics added 6.4 percent to 287¼p on a perceived vulnerability to bids and on an upgrade to “buy” from Bridgewell Securities. Meanwhile, software maker Misys added 2.4 percent to 205p on the news that an activist group of investors from the US had taken a 4.4 percent stake in the company and on a reiteration of a “buy” recommendation from UBS.





    October 19, 2006

    Pharma up in London

    Filed under: Companies, Northern Rock, Prudential, Royal Dutch Shell, BP, GlaxoSmithKline, Bradford & Bingley, Alliance & Leicester, Vodafone, AstraZeneca, Imperial Tobacco, HSBC

    London equities markets were lower on Thursday, mainly on declines in financial sectors. The FTSE 100 dropped 0.2 percent to 6,136.5. Meanwhile, the FTSE 250 was 18.6 points lower to 10,323.1.

    Losers among financial institutions included HSBC, down 0.8 percent to £10.05. Also lower were Northern Rock, which fell 0.9 percent to £11.91 and Bradford & Bingley, 1.5 percent lower to 466p. Alliance & Leicester dropped 1.8 percent to £11.09. Ironically, life assurer Prudential, which sent the sector lower when it blamed its predicted losses in the second half on a loss in its internet bank, Egg, itself added 0.9 percent on the day to 635p.

    In the tobacco sector, Imperial Tobacco was 0.4 percent lower to £18.24 on a downgrade from “buy” to “neutral” from Goldman Sachs.

    The oil sector was lower even in the face of expected cuts in production from the Organization of Petroleum Exporting Companies. Royal Dutch Shell dropped 0.6 percent to £18.14, while BP fell 1 percent to 595p.

    Vodafone declined 0.6 percent to 128p on news from the European telecommunications sector. Nokia was down on the session, and there were worries that an offer from Telefonica to not charge for incoming calls to customers traveling in Europe could set off a tariff war.

    The pharmaceuticals sector saw advances as GlaxoSmithKline added 1 percent to £14.90 and AstraZeneca was 1.5 percent higher to £34.74, its highest share price in nearly five years.





    September 8, 2006

    Next up on bids talk

    Filed under: Companies, Regal Petroleum, Antofagasta, AstraZeneca, Next, Vedanta Resources, GCap Media, Xtract Energy

    London equities markets were up on Friday but closed lower over the week, with the FTSE 100 adding 0.36 for the day but dropping 1.2 percent for the week to end at 5,879.3 and the FTSE 250 up 0.32 Friday but down by 1 percent on the week to 9.606.3.

    Miners were down as investors worried that China will say on Monday that it has a large trade surplus, leading to a tightening of monetary policy there. Antofagasta fell 2 percent to 461p, wile Vedanta Resources declined by 3 percent to £13.21.

    GCap Media dropped 4 percent to 200¾p when Merrill Lynch cut its earnings forecast for the company by 42 percent.

    Among pharmaceuticals companies, AstraZeneca was 1.3 percent lower to £33 on a downgrade to “hold” from Citigroup on valuation concerns.

    In the oil sector, Regal Petroleum added 7.2 percent to 119½p, while Xtract Energy was up 32 percent to 10.3p on a new discovery of a shale deposit in Australia that could yield up to 1.6 billion barrels of oil.

    The biggest winner among blue-chips was Next. The fashion retailer gained 3.8 percent to £17.28 on bids rumors, even though analysts were skeptical of the talk.





    July 27, 2006

    FTSE 100 up for fourth day in a row

    Filed under: Companies, Xstrata, Kazakhmys, Antofagasta, Rolls Royce, Centrica, AstraZeneca, Amvescap, Vedanta Resources, SAB Miller, Kingfisher

    The FTSE 100 ended the day 0.9 percent higher on Thursday, at 5,929.5. It was the fourth day of gains in a row for the blue-chip index, during which time it has gained 3.6 percent, or over 210 points. The FTSE 250 was also up on the day, gaining 0.8 percent to 9,362.

    Earnings reports in several sectors helped stocks to advance. Rolls Royce added 5 percent to 442¾p on better than expected half-year results that had Numis Securities raising the target share price on the airplane engine manufacturer from 475p to 525p. Fund manager Amvescap also was higher, by 4.1 percent to 522½p, after releasing its quarterly report. Retailer Kingfisher added 3.5 percent to 244¾p, while Centrica was up 0.1 percent to 292¾p.

    But not all advances on the day were related to earnings reports. SAB Miller added 1.5 percent to £10.44 on a strengthening of the South African rand. The brewer makes a substantial amount of its money in South Africa.

    Miners were up on higher copper prices and on upgrades from UBS. Kazakhmys was up 6.4 percent to £12.61, while Antofagasta gained 4.8 percent to 416½p and Vedanta Resources added 4.7 percent to £13.21. Xstrata was 5.2 percent higher to £21.41 on the news that it will purchase another 5 percent of Canadian nickel producer Falconbridge, for which it has made a bid.

    In the pharmaceutical sector, AstraZeneca was 3.3 percent lower to £13.75 on a disappointing outlook statement that was issued along with its quarterly report.





    July 4, 2006

    Weak pharma hurts FTSE 100

    Filed under: Companies, British Land, Land Securities, Marks & Spencer, Vodafone, AstraZeneca, Hammerson, Shaftesbury, St Modwen, Great Portland Estates

    Equities markets in London were mixed but closed very close to Monday’s levels on Tuesday as investors indulged in profit-taking after gains in the past four trading sessions. The FTSE 100 dropped 0.02 percent, less than a point, to 4,883.5. The FTSE 250 was up 0.09 percent to 9,505.6. With US markets closed for the Independence Day holiday, volume was light with only 1.9 billion shares trading hands.

    The property sector saw gains among both blue-chip and mid-cap stocks. On the 100, both British Land and Land Securities added 2.8 percent, to £13.33 and £18.79 respectively. Hammerson gained 3.1 percent to £12.41. Over on the 250, Shaftesbury was up 4.8 percent to 549p, while St Modwen rose 4.9 percent to 469p and Great Portland Estates gained 534¾p.

    Among telecoms, Vodafone was up 1 percent to 119p on positive comments from Deutsche Bank.

    Positive sentiment from Goldman Sachs sent Marks & Spencer 1.9 percent higher to 598p, as it added the retailer to its ‘Conviction Buy List’.

    On the other hand AstraZeneca dropped 2.7 percent to £32.19 when ING downgraded the drug maker from “buy” to “hold”, saying that its 12.7 percent share price rise in the past month raises issues of valuation.





    June 29, 2006

    UK market volumes rise

    Filed under: Companies, Lloyds TSB, Xstrata, PartyGaming, Kazakhmys, British Energy, AstraZeneca, Vedanta Resources, HBOS, Drax Group

    The London equities markets were higher on Thursday, helped out by better performance yesterday and today in the New York markets. The FTSE 100 added 1.99 percent to 5,791.5, while the FTSE 250 gained 1.1 percent to 9,303.5. There was a bit more activity, with 2.8 billion shares trading hands during the session.

    In the banking sector, Lloyds TSB was up 2.3 percent to 529p amid rumors that Citibank was going to make an offer. HBOS advanced by 0.3 percent to 940p when Morgan Stanley successfully placed 12.5 million shares at that price on behalf of an institutional client.

    Miners saw gains as Citigroup predicted that there would be further consolidation in the sector and as metals prices went higher. Xstrata gained 5.8 percent to £19.88, while Kazakhmys was up 5.9 percent to £11.76 and Vedanta Resources added 6.7 percent to £13.36.

    The utilities sector, on the other hand, was down on the session. British Energy fell 0.4 percent to 671p, while Drax Group dropped 2.4 percent to 824p after the government released proposed quotas for the second phase of its Emissions Trading Scheme and ahead of its first-half trading report. The government plan allots Drax between 1 million and 1.5 million tonnes less in free allowances for emissions than had been expected.

    In the pharmaceuticals sector, AstraZeneca was up 3.5 percent to £32.42 on an upgraded recommendation to “add” on better sales than expected for several of its products.

    PartyGaming added 0.6 percent to 114¼p as rumors circulated that it will purchase a sports betting company.





    June 14, 2006

    Mixed day for homebuilders

    Filed under: Companies, Lloyds TSB, BG Group, Royal Dutch Shell, BP, Tullow Oil, AstraZeneca, Crest Nicholson, Bovis Homes Group, George Wimpey, Barratt Developments

    London equities markets were mixed on Wednesday. The FTSE 100 dropped 0.2 percent to 5,506.8, mostly on declines in the oil sector, while the FTSE 250 added 0.7 percent to 8,782.2. 3.3 billion shares were traded on the day.

    Homebuilders were mixed on bids rumors. Crest Nicholson was up 3.6 percent to 505p on speculation that one of its rivals would purchase the 23.4 percent of its shares now held by Heron International. Bovis Homes was the most mentioned possible buyer, sending its shares 2.2 percent lower to 779½p. However, some analysts see either George Wimpey or Barratt Developments as more likely bidders for the shares. Wimpey added 2.7 percent on the day to 428½p, while Barratt gained 1.1 percent to 868p.

    In the banking sector, Lloyds TSB added 2.4 percent to 515p on an upgrade to “overweight” and an increase to 611p in its target share price by Morgan Stanley.

    Bid rumors in the pharmaceuticals sector sent AstraZeneca 2. 5 percent higher to £30.16 on a revival of talk that Novartis will make an offer. The feeling of some analysts is that these rumors have gained new currency due to the bidding war over German drug maker Schering.

    In the oil sector, BP lost 1.3 percent to 586p. Royal Dutch Shell declined by 1.8 percent to £17.35, while BG Group was down 3.3 percent to 635p. Meanwhile, Tullow Oil dropped 2.3 percent to 300¾p even though rumor had it that Royal Dutch Shell might be planning a bid.





    « Previous PageNext Page »

    Latest Equities News:

  • Europe, US, most Asia markets lower on news, data

  • Equities decline globally on European debt concerns

  • Most global equities markets see declines on commodities prices

  • Europe, Asia markets mixed as Wall Street declines

  • European, US markets see gains as Asia markets remain mixed

  • European equities decline on lower credit rating for Greece

  • European equities markets gain, helped by US jobs report

  • Most global equities markets in decline

  • Europe, US, Asia markets all see declines

  • London markets see gains as most European markets retreat

  • FTSE News copyright 2012 Central Consultants